At MorphoSys we are dedicated to the discovery, development and delivery of innovative therapies for people living with cance ... r and autoimmune diseases. With over three decades of expertise in antibody technology and our profound understanding of disease biology, we are engineering the medicines of tomorrow. As of July 15, 2021, Constellation Pharmaceuticals is a MorphoSys company. Being able to help patients, give them hope and provide them with the best treatment available is the strongest motivation driving our more than 750 employees across Germany and the United States. Every day we come to work driven to make a difference. Headquartered in Planegg near Munich, Germany, the MorphoSys group includes the fully owned U.S. subsidiaries MorphoSys US Inc. based in Boston, MA as well as Constellation Pharmaceuticals, Inc., based in Cambridge, MA. MorphoSys is listed on the Frankfurt Stock Exchange and NASDAQ under the ticker symbol MOR. read more